Bromocriptine – unique formulation of a dopamine agonist for the treatment of type 2 diabetes

Dapagliflozin, a Novel, Selective SGLT2 Inhibitor, Improved Glycemic Control Over 2 Weeks in Patients With Type 2 Diabetes Mellitus

(2009) B Komoroski et al.   CLINICAL PHARMACOLOGY & THERAPEUTICS

The safety and efficacy of liraglutide with or without oral antidiabetic drug therapy in type 2 diabetes: an overview of the LEAD 1-5 studies

(2009) L. Blonde et al.   DIABETES OBESITY & METABOLISM

Brain Glucagon-Like Peptide-1 Regulates Arterial Blood Flow, Heart Rate, and Insulin Sensitivity

(2008) C. Cabou et al.   DIABETES

Relationship of Abdominal Visceral and Subcutaneous Adipose Tissue With Lipoprotein Particle Number and Size in Type 2 Diabetes

(2008) S. Sam et al.   DIABETES

International Diabetes Federation guideline for management of postmeal glucose: a review of recommendations

(2008) A. Ceriello et al.   DIABETIC MEDICINE

Development of multiple complications in type 2 diabetes is associated with the increase of multiple markers of chronic inflammation

(2008) Jawl-Shan Hwang et al.   JOURNAL OF CLINICAL LABORATORY ANALYSIS